Health Condition 1: C950- Acute leukemia of unspecified celltype Health Condition 2: C910- Acute lymphoblastic leukemia [ALL] Health Condition 3: C930- Acute monoblastic/monocytic leukemia Health Condition 4: C920- Acute myeloblastic leukemia Health Condition 5: C926- Acute myeloid leukemia with 11q23-abnormality Health Condition 6: C92A- Acute myeloid leukemia with multilineage dysplasia Health Condition 7: C865- Angioimmunoblastic T-cell lymphoma Health Condition 8: C911- Chronic lymphocytic l
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Tata Memorial Centre Research Administrative council
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients previously treated for acute leukemia and lymphoma that are in complete remission. 2. Age more than or equal to 15 years at the time of inclusion into the study. 3. Those that have completed at least 2 years since their last therapy. 4. Willing to follow up at Tata Memorial Center, Mumbai.
Exclusion criteria
Exclusion criteria: Those that have undergone or are planned for hematopoietic stem cell transplant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients who test positive for any of the screening tests throughout the duration of follow up will be estimated.Timepoint: 12 months, 24 months, 36 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Yield of a subset of the twenty one diagnostic tests 2. Prevalence of a complication 3. To identify clinical and demographic factors associated with “high yield ? tests. Timepoint: 12 months, 24 months, 36 months | — |
Countries
India
Contacts
Public ContactDr Hasmukh Jain
Tata Memorial Centre
Outcome results
None listed